Markets:

Overview

News

Currencies

International

Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

38.05 -2.35 (-5.82%)

Streaming Delayed Price Updated: 12:47 PM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications

June 05, 2022

From NANOBIOTIX

Via Business Wire

NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022

June 02, 2022

From Nanobiotix

Via Business Wire

CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update

May 18, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX Provides First Quarter Operational and Financial Update

May 18, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022

May 17, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX to Participate in Two Upcoming Investor Conferences

May 11, 2022

From Nanobiotix

Via Business Wire

7 Biotech Stocks With Key Catalysts for May ↗

May 11, 2022

The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.

Via InvestorPlace

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

May 10, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022

May 04, 2022

From NANOBIOTIX

Via Business Wire

New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting

May 02, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies ↗

April 12, 2022

Nanobiotix SA (NASDAQ: NBTX)

Via Benzinga

NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3

April 11, 2022

From NANOBOTIX

Via Business Wire

NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F

April 08, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

April 07, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results

March 30, 2022

From NANOBIOTIX

Via Business Wire

NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022

March 16, 2022

From NANOBIOTIX

Via Business Wire

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

February 10, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer

February 09, 2022

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 02, 2022

Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6...

Via Benzinga

NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4

January 26, 2022

From NANOBIOTIX

Via Business Wire

Is Oncolytics Biotech's GOBLET Study Making Headway in the Fight Against Pancreatic and Colorectal Tumors? ↗

January 25, 2022

Photo by Lucas Vasques on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

January 11, 2022

From Nanobiotix

Via Business Wire

NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets

January 10, 2022

From NANOBIOTIX

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer

January 05, 2022

From NANOBIOTIX

Via Business Wire

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022

January 04, 2022

From Nanobiotix

Via Business Wire

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

December 08, 2021

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.